CLINUVEL PHARMACEUTICALS LTD (CLVLF:OTCMKTS)
$5.38 -0.52 (-8.8136%)
Analysed CLINUVEL PHARMACEUTICALS LTD (CLVLF:OTCMKTS) News Sources
High Growth Tech Stocks To Watch In January 2026
28-01-2026
yahoo.com
High Growth Tech Stocks In Australia For February 2026
11-02-2026
yahoo.com
CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study
24-04-2026
yahoo.com
SCENESSE® approved for EPP in Canada
13-07-2026
yahoo.com
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion
27-08-2026
yahoo.com
3 Great Australian Biotech Stocks With P E Under 14
02-10-2026
yahoo.com
Top 3 Australian Biotech Stocks To Watch In October 2026
10-10-2026
yahoo.com
Vita Life Sciences And 2 Other Australian Biotech Stocks To Watch
17-10-2026
yahoo.com
CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026
15-04-2026
yahoo.com
CLINUVEL’s ADS to commence trading on Nasdaq
20-07-2026
yahoo.com
What is the current price of CLINUVEL PHARMACEUTICALS LTD (CLVLF:OTCMKTS)?
The current price of CLINUVEL PHARMACEUTICALS LTD (CLVLF:OTCMKTS) is $5.38.
CLINUVEL PHARMACEUTICALS LTD (CLVLF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of CLINUVEL PHARMACEUTICALS LTD (CLVLF:OTCMKTS) since the previous trading day is $-0.52.
CLINUVEL PHARMACEUTICALS LTD (CLVLF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of CLINUVEL PHARMACEUTICALS LTD (CLVLF:OTCMKTS) since the previous trading day is -8.8136%.
What is the most recent average sentiment score for CLINUVEL PHARMACEUTICALS LTD (CLVLF:OTCMKTS)?
The most recent average sentiment score for CLINUVEL PHARMACEUTICALS LTD (CLVLF:OTCMKTS) is 81 out of 100.
What is the most recent average sentiment for CLINUVEL PHARMACEUTICALS LTD (CLVLF:OTCMKTS)?
The most recent sentiment for CLINUVEL PHARMACEUTICALS LTD (CLVLF:OTCMKTS) is .
SEC-8K** Filing Available For CLINUVEL PHARMACEUTICALS LTD (CLVLF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.